AcuCort AB has signed a partnership agreement for Sweden, Norway, Denmark and Finland with Unimedic Pharma. The agreement means that Unimedic will be responsible for sales and marketing of AcuCort's oral film Zeqmelit®? in these countries.

With the agreement, AcuCort enters the commercialization phase that the company has been preparing for a long time. Previously, the company's oral film Zeq Melit®? has received approval from pharmaceutical authorities in Sweden, Denmark, Norway and Finland, which allows for a commercial venture in these countries.